Genenta Science Spa Stock Performance
| GNTA Stock | USD 4.15 0.23 5.87% |
The company retains a Market Volatility (i.e., Beta) of 0.56, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genenta Science's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genenta Science is expected to be smaller as well. At this point, Genenta Science SpA has a negative expected return of -0.16%. Please make sure to check out Genenta Science's accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Genenta Science SpA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Genenta Science SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return 5.87 | Five Day Return 9.79 | Year To Date Return (8.39) | Ten Year Return (62.27) | All Time Return (62.27) |
1 | Disposition of 506245 shares by Rosenwald Lindsay A Md of Genenta Science subject to Rule 16b-3 | 12/27/2024 |
2 | Italy on the Move returns during the J.P. Morgan Healthcare Conference 2025 - StockTitan | 01/13/2025 |
3 | Is Genenta Science S.p.A. the Best Italian Stock to Buy in 2025 - Yahoo Finance UK | 02/12/2025 |
4 | Genenta Announces 20 million Financing To Expand Pipel | 03/19/2025 |
| Begin Period Cash Flow | 29.8 M | |
| Free Cash Flow | -11.2 M |
Genenta |
Genenta Science Relative Risk vs. Return Landscape
If you would invest 490.00 in Genenta Science SpA on December 22, 2024 and sell it today you would lose (75.00) from holding Genenta Science SpA or give up 15.31% of portfolio value over 90 days. Genenta Science SpA is currently does not generate positive expected returns and assumes 4.6574% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than Genenta, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Genenta Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genenta Science's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genenta Science SpA, and traders can use it to determine the average amount a Genenta Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0353
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GNTA |
Estimated Market Risk
| 4.66 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genenta Science is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genenta Science by adding Genenta Science to a well-diversified portfolio.
Genenta Science Fundamentals Growth
Genenta Stock prices reflect investors' perceptions of the future prospects and financial health of Genenta Science, and Genenta Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genenta Stock performance.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 53.25 M | ||||
| Shares Outstanding | 18.29 M | ||||
| Price To Book | 3.90 X | ||||
| EBITDA | (11.69 M) | ||||
| Net Income | (11.65 M) | ||||
| Cash And Equivalents | 37.24 M | ||||
| Cash Per Share | 2.04 X | ||||
| Total Debt | 14 | ||||
| Current Ratio | 34.15 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | (11.21 M) | ||||
| Earnings Per Share | (0.57) X | ||||
| Market Capitalization | 75.9 M | ||||
| Total Asset | 22.35 M | ||||
| Retained Earnings | (47.14 M) | ||||
| Working Capital | 19.52 M | ||||
About Genenta Science Performance
By analyzing Genenta Science's fundamental ratios, stakeholders can gain valuable insights into Genenta Science's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genenta Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genenta Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 7.9 K | 5.3 K | |
| Return On Tangible Assets | (0.60) | (0.57) | |
| Return On Capital Employed | (0.65) | (0.69) | |
| Return On Assets | (0.60) | (0.57) | |
| Return On Equity | (0.66) | (0.62) |
Things to note about Genenta Science SpA performance evaluation
Checking the ongoing alerts about Genenta Science for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genenta Science SpA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genenta Science SpA generated a negative expected return over the last 90 days | |
| Genenta Science SpA has high historical volatility and very poor performance | |
| Genenta Science SpA has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Genenta Science SpA currently holds about 37.24 M in cash with (11.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04. | |
| Roughly 39.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Genenta Announces 20 million Financing To Expand Pipel |
- Analyzing Genenta Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genenta Science's stock is overvalued or undervalued compared to its peers.
- Examining Genenta Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genenta Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genenta Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genenta Science's stock. These opinions can provide insight into Genenta Science's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Genenta Stock analysis
When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |